-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, EmoVbN6X49pwWJr4Haik/DnD5vjp2zYC1OVPltN+1atuEU3y/hrZ9PHhai2pPyma Bm+c8A6cPYm+YcHuucHfBA== 0001145443-09-001098.txt : 20090504 0001145443-09-001098.hdr.sgml : 20090504 20090504131847 ACCESSION NUMBER: 0001145443-09-001098 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20090429 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers FILED AS OF DATE: 20090504 DATE AS OF CHANGE: 20090504 FILER: COMPANY DATA: COMPANY CONFORMED NAME: POWER 3 MEDICAL PRODUCTS INC CENTRAL INDEX KEY: 0001063530 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 650565144 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-24921 FILM NUMBER: 09792623 BUSINESS ADDRESS: STREET 1: 3400 RESEARCH FOREST DR STREET 2: SUITE B2-3 CITY: THE WOODLANDS STATE: TX ZIP: 77381 BUSINESS PHONE: 281-466-1600 MAIL ADDRESS: STREET 1: 3400 RESEARCH FOREST DR STREET 2: SUITE B2-3 CITY: THE WOODLANDS STATE: TX ZIP: 77381 FORMER COMPANY: FORMER CONFORMED NAME: SURGICAL SAFETY PRODUCTS INC DATE OF NAME CHANGE: 19980924 8-K 1 d24824_8k.htm FORM 8-K UNITED STATES

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C.  20549

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported):  April 29, 2009

POWER3 MEDICAL PRODUCTS, INC.
(Exact name of registrant specified in charter)

New York

000-24921

65-0565144

(State of
Incorporation)

(Commission File
Number)

(IRS Employer
Identification No.)


3400 Research Forest Drive, Suite B2-3
The Woodlands, Texas  77381
(Address of principal executive offices)  (Zip Code)

(281) 466-1600
(Registrant’s telephone number, including area code)

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

[  ]Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

[  ]Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

[  ]Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

[  ]Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))



Section 5 — Corporate Governance and Management

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers


On April 29, 2009, the Board of Directors of Power3 Medical Products, Inc. (the “Company”) appointed John P. Ginzler as Chief Financial Officer of the Company.  Mr. Ginzler replaces Helen R. Park, the Company’s interim Chief Executive Officer, who had been serving as interim Chief Financial Officer of the Company since December 12, 2008.


Mr. Ginzler previously served as Vice President, Finance of Critical Care Systems, Inc., a national provider of infusion therapies, from April 2006 to April 2009.  From March 2005 to April 2006, Mr. Ginzler served as the Director of Accounting, and from June 2003 to March 2005 he served as Assistant Controller, for Critical Care Systems.  Mr. Ginzler has over 20 years of accounting and financial experience in the medical industry.   Mr. Ginzler has an MBA in Entrepreneurship, cum laude, from Babson College and a BS in Accounting, summa cum laude, from Northeastern University.


Mr. Ginzler has no family relationship with any current director or executive officer of the Company.  Mr. Ginzler is currently neither a party to nor participates in any material plan, contract or arrangement with the Company in connection with his appointment as Chief Financial Officer.




2



SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.  

 

Power3 Medical Products, Inc.

 

 

 

 

By:  

               /s/Ira L. Goldknopf               

 

Name:

Ira L. Goldknopf

 

Title:

President and Chief Scientific Officer


Dated: May 4, 2009



3



 -----END PRIVACY-ENHANCED MESSAGE-----